Results 11 to 20 of about 33,462 (192)

Pneumococcal vaccine

open access: yesPrimary Care Update for OB/GYNS, 2001
Pneumococcal infection is responsible for a wide range of diseases, including upper respiratory tract infections such as otitis media and sinusitis, pneumonia and other lower respiratory infections, and the disseminated infections of bacteremia and meningitis.
Department of OB-Gyn, University of Florida, Gainesville, Florida, USA ( host institution )   +1 more
openaire   +6 more sources

Pneumococcal vaccine [PDF]

open access: yesPostgraduate Medical Journal, 1997
Summary Streptococcus pneumoniae is a frequent cause of pneumonia and meningitis. This article looks at the pneumococcal vaccine, its uses, efficacy, and adverse effects and how vaccination may be improved. We also look at the role of the new conjugate vaccines.
K L, Hattotuwa, C R, Hind
openaire   +2 more sources

Pneumococcal vaccine and opsonic pneumococcal antibody [PDF]

open access: yesJournal of Infection and Chemotherapy, 2013
Streptococcus pneumoniae is a major human pathogen responsible for the majority of bacterial pneumonia cases as well as invasive pneumococcal diseases with high mortality and morbidity. Use of conjugate vaccines targeting the pneumococcal capsule has dramatically reduced the incidence of invasive diseases, and there are active efforts to further ...
Joon Young, Song   +3 more
openaire   +2 more sources

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review.

open access: yesPLoS ONE, 2019
BackgroundDespite the widespread implementation of the pneumococcal conjugate vaccine, Streptococcus pneumoniae remains the leading cause of severe pneumonia associated with mortality among children less than 5 years of age worldwide, with the highest ...
James Samwel Ngocho   +6 more
doaj   +1 more source

Pneumococcal Vaccines

open access: yesIndian Journal of Medical Microbiology, 2018
Streptococcus pneumoniae continues to take a heavy toll on childhood mortality and morbidity across the developing world. An estimated 10.6 million invasive pneumococcal diseases (IPDs) occur every year, with nearly 1 million deaths in children under 5 years of age. Introduction of vaccines in the childhood immunisation programme in developed world has
Anand, Manoharan, Ranjith, Jayaraman
openaire   +2 more sources

Population-based estimates of the effectiveness of pneumococcal vaccination in Australia

open access: yesInternational Journal of Population Data Science, 2017
Objectives Australia’s Childhood Immunisation Register (ACIR) is one of only a handful of national immunisation registers world-wide. We have, for the first time, linked the ACIR to other health datasets to measure the real-world impact of Australia’s ...
Heather Gidding   +6 more
doaj   +1 more source

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite   +5 more
doaj   +1 more source

Pneumococcal Vaccines

open access: yesMicrobiology Spectrum, 2014
ABSTRACTStreptococcus pneumoniaeis a Gram-Positive pathogen that is a major causative agent of pneumonia, otitis media, sepsis and meningitis across the world. The World Health Organization estimates that globally over 500,000 children are killed each year by this pathogen. Vaccines offer the best protection againstS. pneumoniaeinfections.
D. E. Briles   +4 more
openaire   +4 more sources

Invasive pneumococcal infection due to serotype 15A after the pneumococcal conjugate vaccine implementation in Turkey

open access: yesHuman Vaccines & Immunotherapeutics, 2017
Invasive pneumococcal infections among children are a serious public health problem in many countries, including Turkey. Pneumococcal conjugate vaccine has been included in Turkey's National Immunization Programme since 2009.
Ayşe Büyükcam   +6 more
doaj   +1 more source

Recent progress in pneumococcal protein vaccines

open access: yesFrontiers in Immunology, 2023
Pneumococcal infections continue to pose a significant global health concern, necessitating the development of effective vaccines. Despite the progress shown by pneumococcal polysaccharide and conjugate vaccines, their limited coverage and the emergence ...
Sha Li   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy